1 Yang, JB (1995) Research report on the etiology of Kaschin-Beck disease (KBD). Chin J Endemiol 14, 201–204.
2 Wang, ZL (2005) Synchronous study on the four kinds of etiological hypotheses of Kashin-Beck disease. J Xi'an Jiaotong Univ Med Sci 26, 1–7.
3 Moreno-Reyes, R, Mathieu, F, Boelaert, M, et al. (2003) Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 78, 137–144.
4 Wang, WZ, Guo, X, Duan, C, et al. (2009) Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthritis Cartilage 17, 83–90.
5 Meplan, C, Crosley, LK, Nicol, F, et al. (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender specific manner (the SELGEN study). FASEB J 21, 3063–3074.
6 Bosschaerts, T, Guilliams, M, Noel, W, et al. (2008) Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol 180, 6168–6175.
7 Rayman, Margaret P (2009) Selenoproteins and human health: insights from epidemiological data. BBA 1790, 1533–1540.
8 Berry, MJ, Banu, L, Harney, JW, et al. (1993) Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J 12, 3315–3322.
9 Alfonso, Calvo, Nianqing, Xiao, Jason, Kang, et al. (2002) Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res 62, 5325–5335.
10 Volker, Mostert (2000) Selenoprotein P: properties functions, and regulation. Arch Biochem Biophys 376, 433–438.
11 Sasakura, C & Suzuki, KT (1998) Biological interaction between transitionmetals (Ag Cd and Hg), selenide/sulfide and selenoprotein P. J Inorg Biochem 71, 159–162.
12 Al-Taie, OH, Seufert, J, Mörk, H, et al. (2002) A complex DNA- repeat structure within the selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet 10, 499–504.
13 Peters, U, Chatterjee, N, Hayes, RB, et al. (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17, 1144–1153.
14 Saadat, M (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97, 505–509.
15 Fujii, M, Saijoh, K & Sumino, K (1997) Regulation of selenoprotein P mRNA expression in comparison with metallothionein and osteonectin mRNAs following cadmium and dexamethasone administration. Kobe J Med Sci 43, 13–23.
16 Jing, SY, Zhao, SS & Fu, LJ (2006) The biochemistry of selenium and glutathione system. Feed Industry 27, 8–11.
17 Moschos, MP (2000) Selenoprotein P. Cell Mol Life Sci 57, 1836–1845.
18 Artl, GE, Mostert, V, Oubrahim, H, et al. (1998) Portection by selenoprotein P in human plasma against peroxynirtite-mediated oxidation and nitration. Biol Chem 379, 1201–1205.
19 Mostert, V, Dreher, I, Kohrle, J, et al. (1999) Transforming growth factor-beta1 inhibits expression of selenoprotein P in cultured human liver cells. FEBS Lett 460, 23–26.
20 Hesse-Bahr, K, Dreher, I & Kohrle, J (2000) The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. Biofactors 11, 83–85.